CALMYLIN

Google image searchProduct monograph

Active ingredients

codeine phosphate, 3.33 MG/5 ML

diphenhydramine hydrochloride, 12.5 MG/5 ML

ammonium chloride, 125 MG/5 ML

DIN: 00535230

Dosage form(s): SYRUP

Route(s) of administration: ORAL

Schedule: Narcotic (CDSA I)

Company: TEVA CANADA LIMITED

Date: 24-APR-2013

ATC:

• R05 — COUGH AND COLD PREPARATIONS (ATC, ATC/DDD, )
• R05F — COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS (ATC, ATC/DDD)
• R05FA — Opium derivatives and expectorants (ATC, ATC/DDD)
• R05FA02 — OPIUM DERIVATIVES AND EXPECTORANTS (ATC/DDD)

Pharmaceutical standard: MFR

External Links for Calmylin

Search on Google

• Calmylin side effects
• Calmylin dosage
• codeine phosphate side effects
• codeine phosphate dosage
• diphenhydramine hydrochloride side effects
• diphenhydramine hydrochloride dosage
• ammonium chloride side effects
• ammonium chloride dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find calmylin photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.